AstraZeneca PLC Claim profile
ISIN: GB0009895292 | Ticker: AZN | LEI: PY6ZZQWO2IZFZC3IOL08
We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science can do.
We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally. We have three priorities designed to deliver our growth through innovation strategy.
Oncology
We are leading a revolution in oncology to redefine cancer care. Our ambition is to provide cures for cancer in every form.
BioPharmaceuticals
We want to change the lives of billions of people living with chronic diseases for the better.
Rare Disease
Our mission is to transform the lives of people affected by rare diseases and devastating conditions.
1999
Served areaWorldwide
Headquarters1 Francis Crick Avenue, CB2 0AA Cambridge – United Kingdom
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | ENG | |||
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | ENG | |||
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
1,549,800,030
IPOJune 1, 1993
Stock exchange(s)London Stock Exchange
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.